Literature DB >> 30100082

Imaging Tumor Proliferation in Breast Cancer: Current Update on Predictive Imaging Biomarkers.

Azadeh Elmi1, Elizabeth S McDonald1, David Mankoff2.   

Abstract

Uncontrolled growth is a hallmark of cancer; imaging cell proliferation can provides an early indicator of therapeutic response. This capability is especially well-matched to the emerging cell cycle-specific chemotherapeutics with the goal of identifying patients that benefit from these treatments early in the course of treatment to guide personalized therapy. This article focuses on investigational cell proliferation imaging PET radiotracers to evaluate tumor proliferation in the setting of cell cycle-targeted chemotherapy and endocrine therapy for metastatic breast cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; PET imaging; Radiotracer; Targeted therapies; Tumor proliferation

Mesh:

Substances:

Year:  2018        PMID: 30100082      PMCID: PMC6092945          DOI: 10.1016/j.cpet.2018.02.007

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  75 in total

1.  Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil.

Authors:  T C Chou; X B Kong; M P Fanucchi; Y C Cheng; K Takahashi; K A Watanabe; J J Fox
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  Assessment of tumor response to chemotherapy in patients with breast cancer using (18)F-FLT: a meta-analysis.

Authors:  Sheng-Ming Deng; Wei Zhang; Bin Zhang; Yi-Wei Wu
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

Review 3.  Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.

Authors:  Conleth G Murphy; Maura N Dickler
Journal:  Endocr Relat Cancer       Date:  2016-07-12       Impact factor: 5.678

4.  Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells.

Authors:  Elizabeth S McDonald; Julia Mankoff; Mehran Makvandi; Wenhua Chu; Yunxiang Chu; Robert H Mach; Chenbo Zeng
Journal:  Biochem Biophys Res Commun       Date:  2017-03-24       Impact factor: 3.575

Review 5.  18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.

Authors:  Geraldine J Liao; Amy S Clark; Erin K Schubert; David A Mankoff
Journal:  J Nucl Med       Date:  2016-06-15       Impact factor: 10.057

6.  Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

Authors:  R H Mach; C R Smith; I al-Nabulsi; B R Whirrett; S R Childers; K T Wheeler
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

7.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

8.  IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.

Authors:  Carlo Palmieri; Richard Szydlo; Marie Miller; Laura Barker; Neva H Patel; Hironobu Sasano; Tara Barwick; Henry Tam; Dimitri Hadjiminas; Jasmin Lee; Abeer Shaaban; Hanna Nicholas; R Charles Coombes; Laura M Kenny
Journal:  Breast Cancer Res Treat       Date:  2017-08-09       Impact factor: 4.872

9.  Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.

Authors:  Mitch Dowsett; Jack Cuzick; Jim Ingle; Alan Coates; John Forbes; Judith Bliss; Marc Buyse; Michael Baum; Aman Buzdar; Marco Colleoni; Charles Coombes; Claire Snowdon; Michael Gnant; Raimund Jakesz; Manfred Kaufmann; Francesco Boccardo; Jon Godwin; Christina Davies; Richard Peto
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

10.  Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer.

Authors:  M Loddo; S R Kingsbury; M Rashid; I Proctor; C Holt; J Young; S El-Sheikh; M Falzon; K L Eward; T Prevost; R Sainsbury; K Stoeber; G H Williams
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  2 in total

Review 1.  PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies.

Authors:  Matthew F Covington; Bhasker R Koppula; Gabriel C Fine; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

2.  Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status.

Authors:  Elizabeth S McDonald; Robert K Doot; Anthony J Young; Erin K Schubert; Julia Tchou; Daniel A Pryma; Michael D Farwell; Anupma Nayak; Amy Ziober; Michael D Feldman; Angela DeMichele; Amy S Clark; Payal D Shah; Hsiaoju Lee; Sean D Carlin; Robert H Mach; David A Mankoff
Journal:  J Nucl Med       Date:  2019-12-13       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.